Gadopiclenol Pharmacokinetics, Safety and Efficacy in Pediatric Patients < 2 Years of Age
Latest Information Update: 31 Oct 2025
At a glance
- Drugs Gadopiclenol (Primary)
- Indications CNS disorders; Liver cancer
- Focus Pharmacokinetics
- Sponsors Guerbet
Most Recent Events
- 28 Mar 2025 Protocol was amended to add Parallel to the study design
- 18 Mar 2025 Protocol was amended to change the study intervention from Parallel Assignment to Single Group Assignment.
- 18 Mar 2025 Status changed from active, no longer recruiting to completed.